A detailed history of Quadrant Capital Group LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 32 shares of GH stock, worth $966. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32
Previous 32 -0.0%
Holding current value
$966
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$16.07 - $31.84 $32 - $63
-2 Reduced 5.88%
32 $0
Q1 2024

May 15, 2024

SELL
$17.13 - $26.91 $2,124 - $3,336
-124 Reduced 78.48%
34 $0
Q4 2023

Feb 08, 2024

SELL
$21.58 - $29.5 $1,402 - $1,917
-65 Reduced 29.15%
158 $4,000
Q3 2023

Nov 14, 2023

BUY
$25.8 - $39.97 $748 - $1,159
29 Added 14.95%
223 $6,000
Q2 2023

Aug 09, 2023

BUY
$20.94 - $38.01 $3,517 - $6,385
168 Added 646.15%
194 $6,000
Q1 2023

May 11, 2023

SELL
$22.92 - $33.76 $2,406 - $3,544
-105 Reduced 80.15%
26 $0
Q4 2022

Feb 10, 2023

SELL
$25.44 - $59.78 $1,297 - $3,048
-51 Reduced 28.02%
131 $3,000
Q3 2022

Nov 10, 2022

SELL
$43.66 - $61.0 $436 - $610
-10 Reduced 5.21%
182 $10,000
Q2 2022

Aug 09, 2022

BUY
$28.82 - $77.35 $1,296 - $3,480
45 Added 30.61%
192 $8,000
Q1 2022

May 06, 2022

BUY
$48.25 - $100.49 $1,930 - $4,019
40 Added 37.38%
147 $10,000
Q4 2021

Feb 01, 2022

BUY
$88.71 - $120.43 $2,306 - $3,131
26 Added 32.1%
107 $11,000
Q3 2021

Nov 12, 2021

BUY
$98.77 - $132.17 $1,185 - $1,586
12 Added 17.39%
81 $10,000
Q1 2021

May 12, 2021

BUY
$127.04 - $179.1 $1,016 - $1,432
8 Added 13.11%
69 $11,000
Q4 2020

Feb 16, 2021

BUY
$99.96 - $135.93 $1,599 - $2,174
16 Added 35.56%
61 $8,000
Q3 2020

Nov 13, 2020

SELL
$80.32 - $111.8 $13,895 - $19,341
-173 Reduced 79.36%
45 $5,000
Q2 2020

Aug 13, 2020

BUY
$60.49 - $97.5 $11,372 - $18,330
188 Added 626.67%
218 $18,000
Q1 2020

May 15, 2020

BUY
$59.04 - $88.81 $1,771 - $2,664
30 New
30 $2,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.09B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.